German Health Data Providers Compared: Claims Data Access, GDNG Compliance and RWE Fit for Pharma Research
Germany has one of the most analytically valuable health data environments in Europe — and one of the most structurally
Outcome Prediction Models in Healthcare: Using RWD to Build Predictive Analytics
Here’s the version of predictive modelling in pharma that doesn’t get discussed enough in vendor conversations: the one where the
Outcome Prediction Models in Healthcare: Using RWD to Build Predictive Analytics Read Post »
Longitudinal Data Analysis in Pharma: What Makes a Dataset Fit for Purpose
Here’s a pattern we see repeatedly in the RWE programmes we advise on across Continental European markets: a company selects
Longitudinal Data Analysis in Pharma: What Makes a Dataset Fit for Purpose Read Post »
Phenotype Validation in Claims Data: The RWE Step That Determines Whether Your Study Stands or Falls
Here’s something we see consistently in the RWE programmes we advise on: teams invest months in study design, data access
Pan-European Real-World Data for Pharma: How to Navigate Fragmented Claims Data Across Pan-European Markets for Multi-Market Launch
Most RWE teams in pharma are fluent in US claims logic. They know Optum. They know IBM MarketScan. They know
How to Make the Case for RWE Investment Internally: A Guide to Pharma Data Procurement, GDPR Compliance and Stakeholder Buy-In
Here’s a scenario that will feel uncomfortably familiar to anyone who has tried to initiate a real-world data programme inside
Pharma Competitive Intelligence with Real-World Evidence: Tracking Competitor Treatment Patterns, Prescribing Shifts and Real-World Market Share
The Intelligence Gap That’s Costing Brand Teams Strategic Ground Here’s a scenario that plays out more often than anyone in
RWE Strategy for Small Pharma: A Strategic Plan for Pharmaceutical Companies Without a Dedicated Real World Evidence Team
Here’s the assumption that gets small and mid-size pharma companies into trouble more often than any other: that real-world evidence
Real-World Evidence Myths: 5 Things Pharma Teams Get Wrong About RWE, Claims Data and Study Design
Every year, pharma companies spend tens of millions of dollars on real-world evidence programmes that fail to deliver what was
Why Pharma Data Scientists Spend 70% of Their Time on Data Engineering — And How Analysis-Ready RWD Changes That
The pharmaceutical industry has reached an inflection point. Real-world evidence isn’t a nice-to-have anymore—it’s the foundation for every major strategic